Data / Form D filings / REPROS THERAPEUTICS INC.
REPROS THERAPEUTICS INC.: Form D filings
REPROS THERAPEUTICS INC., a biotechnology company in Woodlands, TX, filed 2 Form D notices with the SEC between 2009 and 2012. The latest, on September 19, 2012, reports $23.6 million sold of a $23.6 million offering to 15 investors.
Find out what REPROS THERAPEUTICS INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2408 TIMBERLOCH PL, SUITE B-7, Woodlands, TX, 77380
- Phone
- (281) 719-3400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 897075
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 19, 2012 | New notice | $23,601,997 | $23,601,997 | $0 | 15 | Sep 7, 2012 | sec.gov |
| Nov 12, 2009 | New notice | $6,054,227 | $5,897,313 | $156,914 | 9 | Oct 29, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel S. Cain | Director | |
| Michael S. Wyllie, Ph.D. | Director | |
| Jean S. Fourcroy | Director | |
| Katherine S. Anderson | Executive Officer | |
| Jaye S. Thompson, Ph.D. | Director | |
| Joseph S. Podolski | Executive Officer, Director | |
| Nola S. Masterson | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Sep 17, 2012 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what REPROS THERAPEUTICS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.